Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-04 | New | $232,149 | $232,149 | Other | 06b | SEC link |
| 2025-01-28 | New | $152,500 | $152,500 | Other | 06b | SEC link |
| 2025-01-28 | New | $208,334 | $208,334 | Other | 06b | SEC link |
| 2025-01-28 | New | $265,918 | $265,918 | Other | 06b | SEC link |
| 2025-01-07 | New | $30,000 | $30,000 | Other | 06b | SEC link |
| 2025-01-03 | New | $54,649 | $54,649 | Other | 06b | SEC link |
| 2024-07-24 | New | $136,322 | $136,322 | Other | 06b | SEC link |
| 2023-12-19 | New | $532,563 | $532,563 | Other | 06b | SEC link |
| 2023-06-13 | New | $2,999,373 | $2,999,373 | Equity Only | 06b | SEC link |
| 2023-05-02 | New | $4,010,519 | $4,010,519 | Other | 06b | SEC link |
| 2022-11-23 | New | $1,750 | $1,750 | Equity Only | 06b | SEC link |
| 2021-02-16 | New | $14,001,909 | $14,001,909 | Equity Only | 06b | SEC link |
| 2020-04-14 | New | $4,375,011 | $4,375,011 | Other | 06b | SEC link |
| 2020-02-24 | New | $1,903,128 | $1,903,128 | Other | 06b | SEC link |
| 2018-08-17 | Amended | $1,937,904 | $1,676,904 | Equity Only | 06b | SEC link |
| 2017-08-18 | New | $261,000 | $261,000 | Equity Only | 06b | SEC link |
| 2013-03-26 | New | $23,628,750 | $23,628,750 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Robert J. Bitterman | Director, Executive |
| Patricia A. Bradford | Director |
| Keith Brownlie | Director |
| Lisa Carson | Executive |
| Geert Cauwenbergh | Director |
| David H. Deming | Director |
| Gerrit Dispersyn | Director, Executive |
| Paul Dorman | Director |
| H. Paul Dorman | Director |
| H Paul Dorman | Director |
| Alexey Eliseev | Executive |
| Robert Ferrara | Director |
| Jonathan Freeman | Director |
| Robert Infarinato | Executive, Promoter |
| Caitlin Kontulis | Executive |
| Curtis A Lockshin | Director |
| Curtis Lockshin, Ph.D. | Director |
| Pamela Pavco | Executive |